JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC episode artwork

EPISODE · May 31, 2026 · 8 MIN

JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC

from Journal of Clinical Oncology (JCO) Podcast

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultaneous Publication paper "Neoadjuvant Sacituzumab Govitecan in Patients with Muscle-Invasive Bladder Cancer: Primary Results of SURE-01 Trial." LINK TO FULL TRANSCRIPT

Episode metadata supplied by the publisher feed · Published May 31, 2026

Embed this episode

NOW PLAYING

JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC

0:00 8:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 8 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on May 31, 2026.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!